Role of salsolinol in the regulation of pituitary prolactin and peripheral dopamine release

Márk Oláh, I. Bodnár, Galit Daniel, B. Tóth, M. Vecsernyés, György M. Nagy

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

(R)-Salsolinol (SAL), a dopamine (DA)-related tetrahydroisoquinoline, has been found in extracts of the neuro-intermediate lobes (NIL) of pituitary glands and in the median eminence of the hypothalamus obtained from intact male rats and from ovariectomized and lactating female rats. Moreover, analysis of SAL concentrations in NIL revealed parallel increases with plasma prolactin (PRL) in lactating rats exposed to a brief (10 min) suckling stimulus after 4-h separation. SAL is sufficiently potent in vivo to account for the massive discharge of PRL that occurs after physiological stimuli (i.e. suckling). At the same time, it was without effect on the secretion of other pituitary hormones. It has been also shown that another isoquinoline derivative, 1-methyldihydroisoquinoline (1MeDIQ), which is a structural analogue of SAL, can dose-dependently inhibit the in-vivo PRL-releasing effect of SAL. Moreover, 1MeDIQ can inhibit the elevation of plasma PRL induced by physiological stimuli, for example suckling, or in different stressful situations also. 1MeDIQ also has a psycho-stimulant action, which is fairly similar to the effect of amphetamine, i.e. it induces an increase in plasma catecholamine concentrations. It is clear from these data that this newly discovered endogenous compound could be involved in regulation of pituitary PRL secretion. It has also been observed that SAL is present in peripheral, sympathetically innervated organs, for example the atrium, spleen, liver, ovaries, vas deferens, and salivary gland. Furthermore, SAL treatment of rats results in dose-dependent and time-dependent depletion of the DA content of the organs listed above without having any effect on the concentration of norepinephrine. More importantly, this effect of SAL can be completely prevented by amphetamine and by 1MeDIQ pretreatment. It is clear there is a mutual interaction between SAL, 1MeDIQ, and amphetamine or alcohol, not only on PRL release; their interaction with catecholamine "synthesis/metabolism" of sympathetic nerve terminals is also obvious.

Original languageEnglish
Pages (from-to)143-151
Number of pages9
JournalReproductive Medicine and Biology
Volume10
Issue number3
DOIs
Publication statusPublished - Sep 2011

Fingerprint

Prolactin
Dopamine
Amphetamine
Intermediate Pituitary Gland
Catecholamines
Tetrahydroisoquinolines
salsolinol
Median Eminence
Pituitary Hormones
Vas Deferens
Salivary Glands
Hypothalamus
Ovary
Norepinephrine
Spleen
Alcohols
Liver

Keywords

  • Alcohol
  • Amphetamine
  • Peripheral dopamine
  • Prolactin
  • Salsolinol

ASJC Scopus subject areas

  • Reproductive Medicine
  • Cell Biology

Cite this

Role of salsolinol in the regulation of pituitary prolactin and peripheral dopamine release. / Oláh, Márk; Bodnár, I.; Daniel, Galit; Tóth, B.; Vecsernyés, M.; Nagy, György M.

In: Reproductive Medicine and Biology, Vol. 10, No. 3, 09.2011, p. 143-151.

Research output: Contribution to journalArticle

@article{67c4f3b2b526459dbbc5dec3e5e396f4,
title = "Role of salsolinol in the regulation of pituitary prolactin and peripheral dopamine release",
abstract = "(R)-Salsolinol (SAL), a dopamine (DA)-related tetrahydroisoquinoline, has been found in extracts of the neuro-intermediate lobes (NIL) of pituitary glands and in the median eminence of the hypothalamus obtained from intact male rats and from ovariectomized and lactating female rats. Moreover, analysis of SAL concentrations in NIL revealed parallel increases with plasma prolactin (PRL) in lactating rats exposed to a brief (10 min) suckling stimulus after 4-h separation. SAL is sufficiently potent in vivo to account for the massive discharge of PRL that occurs after physiological stimuli (i.e. suckling). At the same time, it was without effect on the secretion of other pituitary hormones. It has been also shown that another isoquinoline derivative, 1-methyldihydroisoquinoline (1MeDIQ), which is a structural analogue of SAL, can dose-dependently inhibit the in-vivo PRL-releasing effect of SAL. Moreover, 1MeDIQ can inhibit the elevation of plasma PRL induced by physiological stimuli, for example suckling, or in different stressful situations also. 1MeDIQ also has a psycho-stimulant action, which is fairly similar to the effect of amphetamine, i.e. it induces an increase in plasma catecholamine concentrations. It is clear from these data that this newly discovered endogenous compound could be involved in regulation of pituitary PRL secretion. It has also been observed that SAL is present in peripheral, sympathetically innervated organs, for example the atrium, spleen, liver, ovaries, vas deferens, and salivary gland. Furthermore, SAL treatment of rats results in dose-dependent and time-dependent depletion of the DA content of the organs listed above without having any effect on the concentration of norepinephrine. More importantly, this effect of SAL can be completely prevented by amphetamine and by 1MeDIQ pretreatment. It is clear there is a mutual interaction between SAL, 1MeDIQ, and amphetamine or alcohol, not only on PRL release; their interaction with catecholamine {"}synthesis/metabolism{"} of sympathetic nerve terminals is also obvious.",
keywords = "Alcohol, Amphetamine, Peripheral dopamine, Prolactin, Salsolinol",
author = "M{\'a}rk Ol{\'a}h and I. Bodn{\'a}r and Galit Daniel and B. T{\'o}th and M. Vecserny{\'e}s and Nagy, {Gy{\"o}rgy M.}",
year = "2011",
month = "9",
doi = "10.1007/s12522-011-0086-5",
language = "English",
volume = "10",
pages = "143--151",
journal = "Reproductive Medicine and Biology",
issn = "1445-5781",
publisher = "Springer Japan",
number = "3",

}

TY - JOUR

T1 - Role of salsolinol in the regulation of pituitary prolactin and peripheral dopamine release

AU - Oláh, Márk

AU - Bodnár, I.

AU - Daniel, Galit

AU - Tóth, B.

AU - Vecsernyés, M.

AU - Nagy, György M.

PY - 2011/9

Y1 - 2011/9

N2 - (R)-Salsolinol (SAL), a dopamine (DA)-related tetrahydroisoquinoline, has been found in extracts of the neuro-intermediate lobes (NIL) of pituitary glands and in the median eminence of the hypothalamus obtained from intact male rats and from ovariectomized and lactating female rats. Moreover, analysis of SAL concentrations in NIL revealed parallel increases with plasma prolactin (PRL) in lactating rats exposed to a brief (10 min) suckling stimulus after 4-h separation. SAL is sufficiently potent in vivo to account for the massive discharge of PRL that occurs after physiological stimuli (i.e. suckling). At the same time, it was without effect on the secretion of other pituitary hormones. It has been also shown that another isoquinoline derivative, 1-methyldihydroisoquinoline (1MeDIQ), which is a structural analogue of SAL, can dose-dependently inhibit the in-vivo PRL-releasing effect of SAL. Moreover, 1MeDIQ can inhibit the elevation of plasma PRL induced by physiological stimuli, for example suckling, or in different stressful situations also. 1MeDIQ also has a psycho-stimulant action, which is fairly similar to the effect of amphetamine, i.e. it induces an increase in plasma catecholamine concentrations. It is clear from these data that this newly discovered endogenous compound could be involved in regulation of pituitary PRL secretion. It has also been observed that SAL is present in peripheral, sympathetically innervated organs, for example the atrium, spleen, liver, ovaries, vas deferens, and salivary gland. Furthermore, SAL treatment of rats results in dose-dependent and time-dependent depletion of the DA content of the organs listed above without having any effect on the concentration of norepinephrine. More importantly, this effect of SAL can be completely prevented by amphetamine and by 1MeDIQ pretreatment. It is clear there is a mutual interaction between SAL, 1MeDIQ, and amphetamine or alcohol, not only on PRL release; their interaction with catecholamine "synthesis/metabolism" of sympathetic nerve terminals is also obvious.

AB - (R)-Salsolinol (SAL), a dopamine (DA)-related tetrahydroisoquinoline, has been found in extracts of the neuro-intermediate lobes (NIL) of pituitary glands and in the median eminence of the hypothalamus obtained from intact male rats and from ovariectomized and lactating female rats. Moreover, analysis of SAL concentrations in NIL revealed parallel increases with plasma prolactin (PRL) in lactating rats exposed to a brief (10 min) suckling stimulus after 4-h separation. SAL is sufficiently potent in vivo to account for the massive discharge of PRL that occurs after physiological stimuli (i.e. suckling). At the same time, it was without effect on the secretion of other pituitary hormones. It has been also shown that another isoquinoline derivative, 1-methyldihydroisoquinoline (1MeDIQ), which is a structural analogue of SAL, can dose-dependently inhibit the in-vivo PRL-releasing effect of SAL. Moreover, 1MeDIQ can inhibit the elevation of plasma PRL induced by physiological stimuli, for example suckling, or in different stressful situations also. 1MeDIQ also has a psycho-stimulant action, which is fairly similar to the effect of amphetamine, i.e. it induces an increase in plasma catecholamine concentrations. It is clear from these data that this newly discovered endogenous compound could be involved in regulation of pituitary PRL secretion. It has also been observed that SAL is present in peripheral, sympathetically innervated organs, for example the atrium, spleen, liver, ovaries, vas deferens, and salivary gland. Furthermore, SAL treatment of rats results in dose-dependent and time-dependent depletion of the DA content of the organs listed above without having any effect on the concentration of norepinephrine. More importantly, this effect of SAL can be completely prevented by amphetamine and by 1MeDIQ pretreatment. It is clear there is a mutual interaction between SAL, 1MeDIQ, and amphetamine or alcohol, not only on PRL release; their interaction with catecholamine "synthesis/metabolism" of sympathetic nerve terminals is also obvious.

KW - Alcohol

KW - Amphetamine

KW - Peripheral dopamine

KW - Prolactin

KW - Salsolinol

UR - http://www.scopus.com/inward/record.url?scp=80054962623&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054962623&partnerID=8YFLogxK

U2 - 10.1007/s12522-011-0086-5

DO - 10.1007/s12522-011-0086-5

M3 - Article

AN - SCOPUS:80054962623

VL - 10

SP - 143

EP - 151

JO - Reproductive Medicine and Biology

JF - Reproductive Medicine and Biology

SN - 1445-5781

IS - 3

ER -